Efficacy of high thiamine dosage in treating patients with biotin thiamine responsive basal ganglia disease: a two case reports

Abdullah Nasser Aldosari
DOI: https://doi.org/10.1080/00207454.2024.2352769
2024-05-13
International Journal of Neuroscience
Abstract:Background Biotin-thiamine-responsive basal ganglia disease (BTBGD) is a rare, autosomal recessive neurometabolic disorder caused by mutations in the SLC19A3 gene and characterized by recurrent sub-acute episodes of encephalopathy. Patients with BTBGD have classical neuroimaging findings and a dramatic response to high doses of thiamine.
neurosciences
What problem does this paper attempt to address?